Owner Aventis Pharma S.A. Centre National de la Recherche Scientifique Institut National De La Sante Et De La Recherche Medicale

Inventors Vigneron, Jean-Pierre; Lehn, JeanMarie; Lehn, Pierre

Agent Watermark

Pub. Number AU-B-2002334051

PCT Number PCT/FR02/02959

PCT Pub. Number WO2003/018603

Priority 01/11199 29.08.01 FR; 60/331,452 16.11.01 US

Filing date 29 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 15 May 2008

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen